The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Dendritic cell (DC) based cryoimmunotherapy (CryoIT) in a prospective phase I trial of metastatic castration resistant prostate cancer (mCRPC): Interim analysis.
 
Alfred Honoré
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Liv Cecilie Vestrheim Thomsen
No Relationships to Disclose
 
Bjarte Almås
No Relationships to Disclose
 
Lars Anders Reisæter
No Relationships to Disclose
 
Jannicke Frugård
No Relationships to Disclose
 
Einar Kleboe Kristoffersen
No Relationships to Disclose
 
Guro Kristin Melve
No Relationships to Disclose
 
Torjan Haslerud
No Relationships to Disclose
 
Jarle Tor Rørvik
No Relationships to Disclose
 
Martin Biermann
No Relationships to Disclose
 
Svein Inge Helle
No Relationships to Disclose
 
Gunnar Kvalheim
No Relationships to Disclose
 
Ole Johan Halvorsen
No Relationships to Disclose
 
Duke Bahn
No Relationships to Disclose
 
Klaus Pantel
Honoraria - Agena Bioscience; Novartis; Pfizer
Consulting or Advisory Role - Novartis; Roche; Sanofi; WntResearch
Research Funding - Janssen Diagnostics
Patents, Royalties, Other Intellectual Property - Application no. WO2016 128125A1
Travel, Accommodations, Expenses - Agena Bioscience; Novartis; Pfizer
 
Haakon Ragde
No Relationships to Disclose
 
Bjorn T. Gjertsen
Leadership - Alden Cancer Therapy II; Kinn Therapeutics
Stock and Other Ownership Interests - Alden Cancer Therapy II; Kinn Therapeutics
Consulting or Advisory Role - BerGenBio; Novartis; Seagen
Research Funding - Boehringer Ingelheim
Patents, Royalties, Other Intellectual Property - Alden Cancer Therapy II patent application in relation to CryoIT trial.
Travel, Accommodations, Expenses - Novartis; Seagen
 
Anne Margrete Oyan
Stock and Other Ownership Interests - Alden Cancer Therapy II
Patents, Royalties, Other Intellectual Property - Alden Cancer Therapy II
Other Relationship - Alden Cancer Therapy II; Alden Cancer Therapy II (I)
 
Karl-Henning Kalland
Stock and Other Ownership Interests - Alden Cancer Therapy II
Patents, Royalties, Other Intellectual Property - Alden Cancer Therapy II
Other Relationship - Alden Cancer Therapy II; Alden Cancer Therapy II (I)
 
Christian Beisland
Honoraria - Pfizer
Travel, Accommodations, Expenses - Pfizer